H. Lynch

8.3k total citations · 2 hit papers
16 papers, 3.7k citations indexed

About

H. Lynch is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, H. Lynch has authored 16 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pathology and Forensic Medicine, 10 papers in Oncology and 5 papers in Genetics. Recurrent topics in H. Lynch's work include Genetic factors in colorectal cancer (10 papers), BRCA gene mutations in cancer (5 papers) and Cancer Genomics and Diagnostics (5 papers). H. Lynch is often cited by papers focused on Genetic factors in colorectal cancer (10 papers), BRCA gene mutations in cancer (5 papers) and Cancer Genomics and Diagnostics (5 papers). H. Lynch collaborates with scholars based in United States, Netherlands and Canada. H. Lynch's co-authors include Hans F. A. Vasen, Jukka‐Pekka Mecklin, Peter H. Watson, Thomas C. Smyrk, Stanley R. Hamilton, Miguel A. Rodrı́guez-Bigas, C. Richard Boland, Donald E. Henson, Srishti Srivastava and Leslie H. Sobin and has published in prestigious journals such as Nature Genetics, Gastroenterology and JNCI Journal of the National Cancer Institute.

In The Last Decade

H. Lynch

16 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative Group on HNPCC☆

1999 1.8k citations Hans F. A. Vasen, Peter H. Watson et al. Gastroenterology profile →
A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: Meeting Highlights and Bethesda Guidelines

1997 814 citations Miguel A. Rodrı́guez-Bigas, C. Richard Boland et al. JNCI Journal of the National Cancer Institute profile →

Peers

Countries citing papers authored by H. Lynch

Since Specialization

Citations

This map shows the geographic impact of H. Lynch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Lynch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Lynch more than expected).

Fields of papers citing papers by H. Lynch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Lynch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Lynch. The network helps show where H. Lynch may publish in the future.

Co-authorship network of co-authors of H. Lynch

This figure shows the co-authorship network connecting the top 25 collaborators of H. Lynch. A scholar is included among the top collaborators of H. Lynch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Lynch. H. Lynch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Thymidylate Synthase Over-Expression Underlies the Observed Lack of 5-Fu Therapy Benefit for Msi-H Colorectal Cancers 2014 ·Annals of Oncology ·Zoran Gatalica, Semir Vranić, Gargi D. Basu, D. H. Bryant, H. Lynch	1
2	Parental origin of mutation and the risk of breast cancer in a prospective study of women with a BRCA1 or BRCA2 mutation 2012 ·Clinical Genetics ·(unknown), M Llacuachaqui, Jan Lubiński, H. Lynch, Susan Randall Armel, Susan L. Neuhausen, P Ghadirian, Peng Sun, (unknown), (unknown)	12
3	A hMLH1 genomic mutation and associated novel mRNA defects in a hereditary non-polyposis colorectal cancer family 2002 ·Mutation research. Fundamental and molecular mechanisms of mutagenesis ·(unknown), Barbara Franklin, H. Lynch, Joseph A. Knezetic	13
4	Cancer family history and genetic testing: are malpractice adjudications waiting to happen? 2002 ·The American Journal of Gastroenterology ·H. Lynch	7
5	Cáncer de mama hereditario: aspectos clínicos 2001 ·Revista de Senología y Patología Mamaria ·Patrice Watson, H. Lynch	1
6	MLH3: a DNA mismatch repair gene associated with mammalian microsatellite instability 2000 ·Nature Genetics ·Steven M. Lipkin, Victoria Wang, Russell F. Jacoby, Sharmila Banerjee‐Basu, Andreas D. Baxevanis, H. Lynch, (unknown), Francis S. Collins	248
7	HEREDITARY PANCREATIC ADENOCARCINOMA 2000 ·Medical Clinics of North America ·Randall E. Brand, H. Lynch	48
8	Prophylactic Surgery Decisions and Surveillance Practices One Year Following BRCA1/2 Testing 2000 ·Preventive Medicine ·Caryn Lerman, (unknown), Robert T. Croyle, David Main, Carolyn Durham, Carrie Snyder, (unknown), Jane F. Lynch, (unknown), H. Lynch	204
9	New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative Group on HNPCC☆ breakdown → 1999 ·Gastroenterology ·Hans F. A. Vasen, Peter H. Watson, Jukka‐Pekka Mecklin, H. Lynch	1818
10	Molecular Genetics and Clinical-Pathology Features of Hereditary Nonpolyposis Colorectal Carcinoma (Lynch Syndrome) 1998 ·Oncology ·H. Lynch, Thomas C. Smyrk, Jane F. Lynch	54
11	A descriptive study of BRCA1 testing and reactions to disclosure of test results 1997 ·Cancer ·H. Lynch, Stephen J. Lemon, Carolyn Durham, Susan Tinley, (unknown), Jane F. Lynch, (unknown), (unknown), (unknown), Patrice Watson, Caryn Lerman, (unknown), Gilbert Lenoir, Olga Serova, Steven A. Narod	181
12	A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: Meeting Highlights and Bethesda Guidelines breakdown → 1997 ·JNCI Journal of the National Cancer Institute ·Miguel A. Rodrı́guez-Bigas, C. Richard Boland, Stanley R. Hamilton, Donald E. Henson, Srishti Srivastava, Jeremy R. Jass, P. Meera Khan, H. Lynch, Thomas C. Smyrk, Manuel Perucho, Leslie H. Sobin	814
13	Molecular pathology of primary and metastatic ductal pancreatic lesions 1997 ·Cancer ·Bruce Ruggeri, Lingyi Huang, Daniel Berger, Hong Chang, Andres J. Klein–Szanto, Tamra Goodrow, Moira Wood, T. Obara, C. W. Heath, H. Lynch	66
14	Molecular and immunochemical analyses ofRB1 and cyclin D1 in human ductal pancreatic carcinomas and cell lines 1996 ·Molecular Carcinogenesis ·Lingyi Huang, Deborah Lang, Joseph Geradts, (unknown), (unknown), H. Lynch, Bruce Ruggeri	36
15	The risk of endometrial cancer in hereditary nonpolyposis colorectal cancer 1994 ·The American Journal of Medicine ·Patrice Watson, Hans F. A. Vasen, Jukka‐Pekka Mecklin, Heikki Järvinen, H. Lynch	163
16	Colon cancer genetics 1992 ·Cancer ·H. Lynch, Patrice Watson, Thomas C. Smyrk, Stephen J. Lanspa, Bruce M. Boman, C. Richard Boland, Jane F. Lynch, R. Jennifer Cavalieri, (unknown), R. White, David Sidransky, Bert Vogelstein	49

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact